SomnoMed Limited
SOMNF
$0.4361
-$0.0487-10.05%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -3.95M | -5.98M | -8.03M | -7.51M | -7.02M |
| Total Depreciation and Amortization | 3.37M | 3.36M | 3.32M | 3.15M | 2.99M |
| Total Amortization of Deferred Charges | 1.14M | 1.14M | 1.14M | 1.11M | 1.09M |
| Total Other Non-Cash Items | 1.69M | 910.80K | 122.30K | 926.20K | 1.76M |
| Change in Net Operating Assets | -706.50K | -706.50K | -706.50K | -1.40M | -2.12M |
| Cash from Operations | 1.54M | -1.28M | -4.15M | -3.73M | -3.31M |
| Capital Expenditure | -994.70K | -955.10K | -910.40K | -1.06M | -1.21M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.98M | -2.29M | -2.59M | -2.19M | -1.79M |
| Cash from Investing | -2.98M | -3.25M | -3.50M | -3.24M | -3.01M |
| Total Debt Issued | -- | -- | -- | 140.60K | 281.20K |
| Total Debt Repaid | -14.47M | -16.90M | -19.33M | -13.94M | -8.56M |
| Issuance of Common Stock | 23.50M | 30.79M | 38.08M | 26.33M | 14.57M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.12M | -2.10M | -2.07M | -1.04M | 0.00 |
| Cash from Financing | 4.55M | 7.73M | 10.94M | 7.51M | 4.07M |
| Foreign Exchange rate Adjustments | 626.30K | 62.90K | -512.00K | -507.00K | -503.60K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.73M | 3.26M | 2.78M | 31.60K | -2.75M |